Comparative effects of cyproterone acetate or a long-acting gonadotropin-releasing hormone agonist in polycystic ovarian disease.

Couzinet, B; Le Strat, N; Brailly, S; Schaison, G

Couzinet, B; Le Strat, N; Brailly, S; Schaison, G.

J Clin Endocrinol Metab ; 63(4): 1031-5, 1986 Oct.

Article in En | MEDLINE | ID: mdl-2943752

Subject(s)

Cyproterone/analogs & derivatives; Gonadotropin-Releasing Hormone/analogs & derivatives; Polycystic Ovary Syndrome/drug therapy; Adult; Androstane-3,17-diol/urine; Androstenedione/blood; Cyproterone/therapeutic use; Cyproterone Acetate; Delayed-Action Preparations; Estradiol/blood; Estrone/blood; Female; Gonadotropin-Releasing Hormone/therapeutic use; Humans; Polycystic Ovary Syndrome/blood; Testosterone/blood; Triptorelin Pamoate

Search on Google

Add to My VHL

XML

PubMed Links

Database: MEDLINE Main subject: Polycystic Ovary Syndrome / Gonadotropin-Releasing Hormone / Cyproterone Type of study: Clinical_trials Limits: Adult / Female / Humans Language: En Journal: J Clin Endocrinol Metab Year: 1986 Type: Article

Search on Google

Add to My VHL

XML

PubMed Links